Importancia del tracto gastrointestinal en la diabetes de tipo 2. La cirugía metabólica es más que incretinas

International Diabetes Federation. IDF Diabetes Atlas. 7.th Edition. 2015. Brussels, Belgium [consultado 22 Ene 2017]. Disponible en: http://www.idf.org/diabetesatlas Ashcroft, 2012, Diabetes mellitus and the β cell: the last ten years, Cell., 148, 1160, 10.1016/j.cell.2012.02.010 Melvin, 2016, The gut as an endocrine organ: Role in the regulation of food intake and body weight, Curr Atheroscler Rep., 18, 49, 10.1007/s11883-016-0599-9 Seeley, 2015, The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes, Cell Metab., 21, 369, 10.1016/j.cmet.2015.01.001 Vidal, 2013, Diabetes remission following metabolic surgery: Is GLP-1 the Culprit?, Curr Atheroscler Rep, 15, 1, 10.1007/s11883-013-0357-1 Ye, 2014, GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents, Am J Physiol Regul Integr Comp Physiol., 306, R352, 10.1152/ajpregu.00491.2013 Habener, 2017, Pancreas and not gut mediates the GLP-1 induced glucoincretin effect, Cell Metab., 25, 757, 10.1016/j.cmet.2017.03.020 Rubino, 2004, Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease, Ann Surg., 239, 1, 10.1097/01.sla.0000102989.54824.fc Rubino, 2006, The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes, Ann Surg., 244, 741, 10.1097/01.sla.0000224726.61448.1b Salinari, 2017, Down-regulation of insulin sensitivity after oral glucose administration: Evidence for the “anti-incretin effect”, Diabetes., 66, 2756, 10.2337/db17-0234 Duca, 2015, Glucoregulatory relevance of small intestinal nutrient sensing in physiology. Bariatric Surgery, and Pharmacology, Cell Metab., 22, 367, 10.1016/j.cmet.2015.07.003 Patel, 2018, EndoBarrier®: a safe and effective novel treatment for obesity and type 2 diabetes?, Obes Surg., 28, 1980, 10.1007/s11695-018-3123-1 Salinari, 2014, Duodenal-jejunal bypass and jejunectomy improve insulin sensitivity in Goto-Kakizaki diabetic rats without changes in incretins or insulin secretion, Diabetes., 63, 1069, 10.2337/db13-0856 Kwon, 2014, The foregut theory as a possible mechanism of action for the remission of type 2 diabetes in low body mass index patients undergoing subtotal gastrectomy for gastric cancer, Surg Obes Relat Dis, 10, 235, 10.1016/j.soard.2013.09.013 Pacheco, 2007, The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats, Am J Surg., 194, 221, 10.1016/j.amjsurg.2006.11.015 Zubiaga, 2016, The effects of one-anastomosis gastric bypass on glucose metabolism in goto-kakizaki rats, Obes Surg., 26, 2622, 10.1007/s11695-016-2138-8 Goncalves, 2015, Bile routing modification reproduces key features of gastric bypass in rat, Ann Surg., 262, 1006, 10.1097/SLA.0000000000001121 Kohli, 2013, Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids, J Clin Endocrinol Metab., 98, 10.1210/jc.2012-3736 Kohli, 2013, A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery, Endocrinology., 154, 2241, 10.1210/en.2012-2069 Pournaras, 2013, Are bile acids the new gut hormones? Lessons from weight loss surgery models, Endocrinology., 154, 2255, 10.1210/en.2013-1383 Duboc, 2014, The bile acid TGR5 membrane receptor: from basic research to clinical application, Dig Liver Dis., 46, 302, 10.1016/j.dld.2013.10.021 Wu, 2013, Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans, Diabetes Obes Metab., 15, 474, 10.1111/dom.12043 Nightingale, 2016, Small bowel and nutrition Committee of the British Society of Gastroenterology. Guidelines for management of patients with a short bowel, Gut, 55 Baud, 2016, Bile diversion in roux-en-Y gastric bypass modulates sodium-dependent glucose intestinal uptake, Cell Metab., 23, 547, 10.1016/j.cmet.2016.01.018 Song, 2016, Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus, Expert Opin Ther Targets., 20, 1109, 10.1517/14728222.2016.1168808 Shyangdan, 2016, SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: a systematic review and network meta-analysis, BMJ Open, 6, e009417, 10.1136/bmjopen-2015-009417 Wu, 2016, Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis, Lancet Diabetes Endocrinol, 4, 411, 10.1016/S2213-8587(16)00052-8 Baud, 2016, Sodium glucose transport modulation in type 2 diabetes and gastric bypass surgery, Surg Obes Relat Dis., 12, 1206, 10.1016/j.soard.2016.04.022 Takebayashi, 2017, Effect of sodium glucose cotransporter 2 inhibitors with low SGLT2/SGLT1 selectivity on circulating glucagon-like peptide 1 levels in type 2 diabetes mellitus, J Clin Med Res., 9, 745, 10.14740/jocmr3112w Han, 2014, Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective, World J Gastroenterol.;, 20, 17737, 10.3748/wjg.v20.i47.17737 Cox, 2015, Obesity, inflammation, and the gut microbiota, Lancet Diabetes Endocrinol., 3, 207, 10.1016/S2213-8587(14)70134-2 Kreznar, 2017, Host genotype and gut microbiome modulate insulin secretion and diet-induced metabolic phenotypes, Cell Rep., 18, 1739, 10.1016/j.celrep.2017.01.062 Barja-Fernández, 2015, Peripheral signals mediate the beneficial effects of gastric surgery in obesity, Gastroenterol Res Pract., 2015, 560938, 10.1155/2015/560938 Aron-Wisnewsky, 2012, The importance of the gut microbiota after bariatric surgery, Nat Rev Gastroenterol Hepatol., 9, 590, 10.1038/nrgastro.2012.161 Zhang, 2016, Duodenal-jejunal bypass preferentially elevates serum taurine-conjugated bile acids and alters gut microbiota in a diabetic rat model, Obes Surg., 26, 1890, 10.1007/s11695-015-2031-x Cani, 2016, Gut microbiota: Changes in gut microbes and host metabolism: squaring the circle?, Nat Rev Gastroenterol Hepatol., 13, 563, 10.1038/nrgastro.2016.135 De Kort, 2011, Leaky gut and diabetes mellitus: what is the link?, Obes Rev., 12, 449, 10.1111/j.1467-789X.2010.00845.x Membrez, 2008, Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice, The FASEB Journal, 22, 2416, 10.1096/fj.07-102723 Guinane, 2013, Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ, Therap Adv Gastroenterol., 6, 295, 10.1177/1756283X13482996 Cani, 2017, Next-generation beneficial microbes: The case of akkermansia muciniphila, Front Microbiol., 8, 1765, 10.3389/fmicb.2017.01765 Schneeberger, 2015, Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice, Sci Rep., 5, 16643, 10.1038/srep16643 Yan, 2016, Effect of Roux-en-Y gastric bypass surgery on intestinal Akkermansia muciniphila, World J Gastrointest Surg., 8, 301, 10.4240/wjgs.v8.i4.301 Bell, 2015, Changes seen in gut bacteria content and distribution with obesity: causation or association?, Postgrad Med., 127, 863, 10.1080/00325481.2015.1098519 Penhoat, 2014, Intestinal gluconeogenesis is crucial to maintain a physiological fasting glycemia in the absence of hepatic glucose production in mice, Metabolism., 63, 104, 10.1016/j.metabol.2013.09.005 Troy, 2008, Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice, Cell Metabolism., 8, 201, 10.1016/j.cmet.2008.08.008 Yan, 2016, Roux-en-Y gastric bypass surgery suppresses hepatic gluconeogenesis and increases intestinal gluconeogenesis in a T2DM Rat Model, Obes Surg., 26, 2683, 10.1007/s11695-016-2157-5 Battezzati, 2004, Nonhepatic glucose production in humans, Am J Physiol Endocrinol Metab., 286, E129, 10.1152/ajpendo.00486.2002 Warner, 2016, The pathogenesis of resection-associated intestinal adaptation, Cell Mol Gastroenterol Hepatol., 2, 429, 10.1016/j.jcmgh.2016.05.001 Ryan, 2013, Physiology. Food as a hormone. Science, 339, 918 Habegger, 2014, Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia, Gut., 63, 1238, 10.1136/gutjnl-2013-304583 Saeidi, 2013, Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass, Science., 341, 406, 10.1126/science.1235103 Cavin, 2017, Intestinal adaptations after bariatric surgery: Consequences on glucose homeostasis, Trends Endocrinol Metab., 28, 354, 10.1016/j.tem.2017.01.002 Cavin, 2016, Differences in alimentary glucose absorption and intestinal disposal of blood glucose after roux-en-y gastric bypass vs sleeve gastrectomy, Gastroenterology., 150, 454, 10.1053/j.gastro.2015.10.009 Lauti, 2016, Weight regain following sleeve gastrectomy-a systematic review, Obes Surg., 26, 1326, 10.1007/s11695-016-2152-x Liu, 2002, Intake of refined carbohydrates and whole grain foods in relation to risk of type 2 diabetes mellitus and coronary heart disease, J Am Coll Nutr, 21, 298, 10.1080/07315724.2002.10719227 Moss, 2007, Gastrointestinal monitor: automatic titration of jejunal inflow to match peristaltic outflow, J Surg Res., 140, 184, 10.1016/j.jss.2006.12.545 Müller, 2018, Gastrointestinal transit time. Glucose homeostasis and metabolic health: Modulation by dietary fibers, Nutrients., 10 Dirksen, 2013, Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass, Neurogastroenterol Motil., 25, 10.1111/nmo.12087 Nguyen, 2014, Rapid gastric and intestinal transit is a major determinant of changes in blood glucose, intestinal hormones, glucose absorption and postprandial symptoms after gastric bypass, Obesity., 22, 2003, 10.1002/oby.20791 Nguyen, 2015, Effects of posture and meal volume on gastric emptying, intestinal transit, oral glucose tolerance. blood pressure and gastrointestinal symptoms after roux-en-Y gastric bypass, Obes Surg., 25, 1392, 10.1007/s11695-014-1531-4